EndoVE®

Precision interventional endoscopy treatment for gastrointestinal cancer.

The EndoVE® is the first device to allow for endoscopic treatment of gastrointestinal tumours. The treatment is conducted under sedation in less than 20 minutes on outpatient basis. Muscular contractions from the pulses have been eliminated with the new ePORE® generator.

We have conducted a multicentre clinical study to validate the approach, which utilise a fraction of the normal dose of chemotherapy. Side effects to treatment have been minimised as a result and our outpatient solution is financially attractive in terms of treatment and after-care costs.